Poliovirus Therapy Shows Potential as Cancer Vaccine in Lab Studies | Duke Health
Floyd Lab | Duke Radiation Oncology
glioblastoma | Duke Cancer Institute
Polio Injection Shrinks Woman's Brain Tumor - ABC News
Frontiers | Primary Brain Tumor Research Productivity in Southeast Asia and Its Association With Socioeconomic Determinants and Burden of Disease | Oncology
Study: Genetically Modified Poliovirus To Treat Brain Cancer : Shots - Health News : NPR
Clinical Neurology | Duke Neurology
Preston Robert Tisch Brain Tumor Center | Duke Cancer Institute
Cancer breakthrough: Duke clinical trial destroys SC woman's brain tumor
Duke Clinical & Translational Science Institute
Treating neurocognitive, physical limitations in patients with brain cancer | Duke Department of Neurology
Frontiers | Tumor-Specific T Cell Activation in Malignant Brain Tumors | Immunology
Chemo for glioblastoma may work better in morning than evening – Washington University School of Medicine in St. Louis
Duke Cancer Center Brain Tumor Clinic | Brain Cancer, Glioblastoma
Clinical Trial Studies Treating Brain Tumor with Genetically Modified Poliovirus | University Hospitals
Poliovirus To Treat Brain Cancer: A Curious Chronology - DNA Science
Polio virus: Duke researchers looking at cancer treatment | Raleigh News & Observer
Promising Breakthrough Therapy Uses the Poliovirus to Battle Cancer Tumors | The Preston Robert Tisch Brain Tumor Center
Poliovirus Therapy for Glioblastoma has Three-Year Survival Rate of 21 Percent | Duke Today
Promising brain cancer trial given breakthrough status by FDA - CBS News
Clinical Trials | The Preston Robert Tisch Brain Tumor Center
York doctor in Duke clinical trials for his own brain cancer
Poliovirus Therapy for Glioblastoma has Three-Year Survival Rate of 21 Percent | Duke Today
Brain immunology and immunotherapy in brain tumours | Nature Reviews Cancer
Duke Researchers Uncover Pathway in Lung Cancer Brain Metastasis | Duke Health
Poliovirus treatment for glioblastoma posts 'encouraging' survival data, but work remains | FierceBiotech
